Sam Altman Invested $180 Million in a Longevity Startup

Sam Altman put $180 million into Retro Biosciences, a company that aims to delay death by 10 years. Altman’s interest in longevity research dates back at least eight years, per the MIT Technology Review. This was after he heard of…









